Topmost Trends in the Influenza Vaccine Market Forecast to 2030 by Opportunities, Challenges, Growth Factor


Posted November 2, 2021 by bhandvalkar94

The global influenza vaccine market is anticipated to reach US $ 7824.08+ Mn by 2030 growing at a CAGR of +6.6% during the forecast period (2021 – 2030)
 
A comprehensive statistical scope of Influenza Vaccine market has been published by Absolute Markets Insights. By using primary and secondary exploratory techniques, the report offers an in-depth analysis of Influenza Vaccine sector. Moreover, the erudite report study provides penetrative insights into different selling strategies. The report scrutinizes key market players on the basis of revenue, productivity, applications and end users to give an aerial overview of Influenza Vaccine factors. In addition, information obtained from SWOT analysis and analysis by Porter's years allows for a better understanding of current companies. A detailed analysis of demand and supply chain of Influenza Vaccine market also provides detailed description about requirements of global as well as domestic clients.

Top Players of Global Influenza Vaccine Market are Studied: Abbott, AstraZeneca, CSL Limited (Seqirus USA Inc.), Emergent BioSolutions Inc., F. Hoffmann-La Roche Ltd, GSK, Novavax Inc., SANOFI PASTEUR INC., Serum Institute of India Pvt. Ltd., and Sinovac Biotech Ltd. amongst others.

For more information or Query before buying, Visit@ https://www.industryglobalnews24.com/global-influenza-vaccine-market-by-current-industry-status

The global influenza vaccine market is anticipated to reach US $ 7824.08+ Mn by 2030 growing at a CAGR of +6.6% during the forecast period (2021 – 2030)

The quadrivalent flu vaccines category, which dominated the global influenza vaccine market, can save the receiver from four strains of influenza. In influenza A, quadrivalent flu vaccines fight against the H1N1 (swine flu) and H3N2. In influenza B, this vaccine fights against two strains namely Victoria and Yamagata. The quadrivalent flu vaccines are also suitable for not only most age-groups above 18 years of age, but also for children aged 6 or above.

The seasonal category in the global influenza vaccine market held the larger market share in 2020. Influenza viruses change from year to year. Hence, influenza vaccines need to be updated annually to include the viruses that will most likely circulate in the upcoming season. In countries where frequent seasonal changes are common, there is high demand for universal influenza vaccines that offer protection against multiple strains of influenza viruses over multiple influenza seasons.

In 2020, intramuscular injection segment occupied the largest market. It has been the most common form of dosage for influenza prevention for decades. As an inactivated vaccine, the Flu vaccine contains killed influenza virus. As a recombinant vaccine, it is made without using virus particles at all. When healthcare providers inject the vaccine into muscles or skin, they stimulate the immune system to produce an immune response (in the form of antibodies) to the influenza virus.

Global Influenza Vaccine Market:

By Vaccine Type

Trivalent Flu Vaccines
Quadrivalent Flu Vaccines
By Influenza Type

Seasonal
Pandemic
Others
By Type

Live Attenuated Influenza Vaccine (LAIV)
Inactivated Influenza Vaccine (IIV)
Recombinant Influenza Vaccine (RIV)
By Manufacturing Technology

Egg Based
Cell Based
By Packaging

Prefilled Needleless Syringes
Single Dose and Multi-Dose Vial
By Dosage Form

Intramuscular Injection
Intradermal Shot
Nasal Spray
By Age Group

6 months to 4 Years
4 Years to 18 Years
18 Years to 49 Years
49 Years to 65 Years
More than 65 Years
By Distribution Channel

Doctors’ Offices
Healthcare Clinics
Retail Pharmacies
Hospitals
Others
Geographical Analysis: – Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), and market share and growth rate of Global Influenza Vaccine Market these regions, from 2021 to 2030 (forecast), covering:

North America (United States, Canada, Mexico)

Asia-Pacific (China, India, Japan, South Korea, Australia, Indonesia, Malaysia, Philippines, Thailand, Vietnam)

Europe (Germany, France, UK, Italy, Russia, Rest of Europe)

Central & South America (Brazil, Rest of South America)

Middle East & Africa (GCC Countries, Turkey, Egypt, South Africa, Other)

Contact Us:

Company: Absolute Markets Insights

Email id: [email protected]

Phone: +91-740-024-2424

Contact Name: Shreyas Tanna

Website: https://www.absolutemarketsinsights.com/
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Meera Singh
Country India
Categories Research
Tags influenza vaccine market
Last Updated November 2, 2021